Powder dosage drug patent expiration by year – DrugPatentWatch
This chart shows the expiration of patents for powder dosage drugs over the next decade.
Drug patent terms vary. The basic term for a patent is 20 years from the date the patent was filed, which is generally several years before a drug is approved.
This means that drugs may have patent-protected sales for 6-12 years after their release. There are conditions where drug patents can be extended, for example
compensate for time spent waiting for Food and Drug Agency (FDA) review, or responding to FDA requests for pediatric testing.
Expired drug patents can also be used as a direction set for the pharmaceutical industry — a
an increase, or decrease, in the number of anticipated patent expirations can predict the outcome for branded pharmaceutical companies,
generic manufacturers, and for healthcare payers.
The long-term forecasts presented here can help model the pharmaceutical industry’s trends for powder dosage drugs over the coming decades.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published on powder dosage drug patent expiration by year
